| Document |
Document Title |
|
WO/2007/130704A1 |
The process of the present invention can be briefly summarized as depicted in the following scheme: R1is C1-Calkyl, R2 is C1-C6alkyl and Hal is a halogen atom.
|
|
WO/2007/126042A1 |
[PROBLEMS] To provide a novel compound having few adverse side-effects such as bradycardia and also having an excellent effect of reducing the number of lymphocytes in the peripheral blood. [MEANS FOR SOLVING PROBLEMS] Disclosed is a 2-a...
|
|
WO/2007/123718A1 |
1-Heterocyclylamino-2-hydroxy-3-amino-ω-arylalkanes of formula (I) and the salts thereof have renin-inhibiting properties and can be used as antihypertensive, medicinally active ingredients.
|
|
WO/2007/121818A1 |
The invention relates to the use of compounds of formula (X-Ar-Y), in which X and Y respectively are selected independently of one another from the groups H, C-1-8 alkyl and groups as per formulae (Ia), (Ib) or (Ic), together with other ...
|
|
WO/2007/118567A1 |
The present invention provides compounds of the general formula (1) which have microbial and biocidal properties, and the modification of surfaces by means of the aforementioned compounds. The present application further provides coated ...
|
|
WO/2007/118430A1 |
A functional composite material with good curative effect can be made of 66-96wt% tourmaline superfines and/or crystal infrared material superfines, 0.01-30wt% media reinforcing material and 1-5wt% embedding agent, and one or more soft s...
|
|
WO/2007/105668A1 |
The invention provides a novel immobilized Lewis acid catalyst which exhibits high catalytic activity in an aqueous solution and which permits recovery and reuse or long-term continuous use. The invention relates to an immobilized Lewis ...
|
|
WO/2007/077111A1 |
Compounds having bi-cyclic structure comprising a partially unsaturated 6-carbon first cyclic moiety interconnected to a 6-carbon second cyclic moiety second via a divalent linking moiety are provided. The compounds can be used as interm...
|
|
WO/2007/054254A1 |
The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a pr...
|
|
WO/2007/049579A1 |
Disclosed is a photopolymerizable composition containing a squarylium compound represented by the general formula (I) below, a radical initiator and a compound having an ethylenically unsaturated double bond. (I) [In the formula, R1 and ...
|
|
WO/2007/011005A1 |
A process for producing a biaryl compound, comprising reacting an aromatic organic compound with at least one compound selected from the group consisting of an aromatic organoboron compound and a boroxin ring compound in the presence of ...
|
|
WO/2007/007791A1 |
A process for the decomposition and recovery of isocyanate compounds which comprises introducing continuously an isocyanate compound having at least one isocyanate group or at least one group derived from an isocyanate group in a molten ...
|
|
WO/2007/000918A1 |
Benzylamine derivatives having structures represented by the general formula (1): (1) a method for the optical resolution of benzylamine derivatives which comprises using optically active mandelic acid as the reagent for optical resoluti...
|
|
WO/2006/134457A2 |
Synthesis of 2,5-bis-diamine-[l,4]benzoquinonic derivatives having the general formula (I), products and intermediates of said synthesis; the synthesis involves the use of p-benzoquinones having the general formula (IX) and diamines havi...
|
|
WO/2006/128802A2 |
The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined hereinabove which are active at the GABAB receptor and which can be used for the preparation of medicaments useful in the control or preventio...
|
|
WO/2006/125397A1 |
Nonsteroic androgen acceptor regulator compounds of the general formula (I), pharmaceutically acceptable salts thereof, preparation process and pharmaceutically compositions containing the said compounds are disclosed. Such compounds of ...
|
|
WO/2006/126086A2 |
This invention relates to a process for the synthesis of ketomethylene derivatives of the tripeptide Phe-Gly-Pro ("keto-ACE", compound 5a) and analogues thereof. The synthesis process proceeds via an α,ß-unsaturated keto intermediate. ...
|
|
WO2005080314B1 |
A process for the preparation of compound AQ4N of formula (2) or a salt or solvate thereof wherein the said process includes the reaction step: Formula (1), Formula (2), where compound AQ4 of formula (1) is oxidised to compound AQ4N of f...
|
|
WO/2006/091301A2 |
Protecting the security of an entity by using passcodes is disclosed. A passcode device 101 generates a passcode Pi. In an embodiment, the passcode Pi is generated in response to receipt of user information. The passcode Pi 1 is received...
|
|
WO/2006/087166A1 |
Provided is a process for the preparation of N-monosubstituted β-aminoalcohol sulfonates of formula (Ia), (Ib) wherein R1 is C6-20 aryl or C4-12 heteroaryl, each optionally being substituted with one or more halogen atoms and/or one or ...
|
|
WO/2006/085049A2 |
A pro-odorant or pro-flavorant having the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provided that the total number of carbon atoms in the groups R1 and R2 is 10 ...
|
|
WO/2006/085048A2 |
A pro-odorant or pro-flavorant that is liquid at room temperature and has a relatively low viscosity and has the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provid...
|
|
WO/2006/079090A2 |
Methods and inte&pgr nediates for the preparation of Fenoldopam mesylate and ntermediates thereof are provided.
|
|
WO/2006/072785A2 |
The present invention relates to novel base stable ionic liquids and uses thereof as solvents in chemical reactions, especially base catalysed chemical reactions and reactions comprising the use of strong basis.
|
|
WO/2006/072354A1 |
The invention relates to novel squaric acid compounds of formula (I) wherein R, Rl, R1', R2 and X have the designations cited in patent claim (1). Said compounds are SGK inhibitors and can be used to treat SGK-related diseases and illnes...
|
|
WO/2006/069798A1 |
The invention relates to a process for the preparation of a chiral amine, whereby a ketone or aldehyde is contacted with an enantiomerically enriched phenylglycine amide to give an imine, whereby the imine is subsequently contacted with ...
|
|
WO/2006/057323A1 |
A composition for amyloid-associated disease diagnosis, comprising any of a flavone derivative, a chalcone derivative, a styrylchromone derivative and a coumarin derivative. These derivative compounds simultaneously have a high binding s...
|
|
WO/2006/019955A2 |
Disclosed herein are antiviral compounds, such as anti-human cytomegalovirus antiviral compounds, pharmaceutical compositions and antiviral methods.
|
|
WO/2006/003220A1 |
The invention relates to a method of preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles having formula (I), wherein the asterisk (*) represents an asymmetrical carbon and R1 is alkyl C1-C6, the enantiomers or mixtures there...
|
|
WO/2005/119315A2 |
In one aspect, the present invention provides a hyperpolarizable organic chromophore. The chromophore is a nonlinear optically active compound that includes a &pgr -donor conjugated to a &pgr -acceptor through a &pgr -electron conjugated...
|
|
WO/2005/118524A1 |
A preparation method of [(S)-(-)-alpha-methylamino phenylacetone ]2 (2R,3R)-tartaric acid derivates is disclosed, which comprises forming salt from (±) -alphamethylamino phenylacetone, (R)-(+)-alpha-methylamino phenylacetone or (±)...
|
|
WO/2005/116054A1 |
Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection. The disclosed processes use SNAr-type coupling reactions b...
|
|
WO/2005/108347A2 |
The invention relates to substituted enaminones of Formula (I) and their derivatives and the discovery that these compounds modulate the effect of &gammad -aminobutyric acid (GABA) on the GABAA receptor complex in a therapeutically relev...
|
|
WO/2005/099688A2 |
There is provided a CRF receptor antagonist comprising a compound of the formula (I): A-W-Ar wherein, A is a group represented by the formula (A1) or (A2) (wherein, ring Aa is a 5-or 6-membered ring which may be further substituted; ring...
|
|
WO/2005/100300A1 |
A 5-aminolevulinic acid salt which is useful in the fields of microorganisms, fermentation, animals, medical science, plants and so on; a process for producing the same; a medicinal composition containing the same; and a plant vitalizer ...
|
|
WO/2005/084803A1 |
[PROBLEMS] To provide an asymmetric reaction catalyst which is excellent in yield and stereoselectivity and easy of handling and a process for the production of optically active compounds with the same. [MEANS FOR SOLVING PROBLEMS] An as...
|
|
WO2005063665B1 |
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to i...
|
|
WO/2005/080315A1 |
The invention relates to (3,5-diaminophenyl)(2,4-dihydroxyphenyl)methanone and to its acid adducts of formula (I), in which 0 = n = 2 and HX stands for an inorganic or organic acid. The invention also relates to colorants containing said...
|
|
WO/2005/070869A1 |
The present invention describes an improved catalyst and process for the selective hydrogenation of nitro aromatics, nitrosoaromatics and aromatic hydroxyl amines to their corresponding amines using gaseous hydrogen, in the presence of s...
|
|
WO/2005/058269A1 |
Described are merocyanine derivatives of formula (1a) or (1b) wherein n and o are integers from 2 to 4 and aminocyclohexenone intermediates. They are used in protecting human and animal hair and skin from UV radiation.
|
|
WO/2005/053631A1 |
The invention provides a process for producing microcapsules with UV filter activity, wherein at least one type of crosslinkable chromophore with UV-A and/or UV-B and/or UV-C filter activity and optionally at least one type of crosslinka...
|
|
WO/2005/051888A2 |
The invention relates to compounds of the formula (I) in which: i and j=1; R1 is in position 3 or 4 on the phenyl ring and represents a cyano group, an alkoxy group substituted by halogen, a thioalkyl group, an alkylcarbonyl group or an ...
|
|
WO2004112690B1 |
The invention relates to 2-aminobenzoyl-alkylamines, -alkylamides and - alkylthioamides, and their application for treatment or prevention of various physiological conditions.
|
|
WO/2005/042467A1 |
The present invention provides novel quaternary amino-functional chalcone derivatives and analogues exhibiting interesting antibacterial activity. The compounds have the general formula (Y1)m-Ar1(X1)-C(=O)Var2(X2)-(Y2)p (I), wherein V de...
|
|
WO/2005/042481A2 |
Ketoamine compounds and related methods for reactivation of tumor suppressor protein p53.
|
|
WO2004087061B1 |
A diverse set of tubulin binding agents have been discovered which are structurally characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for mol...
|
|
WO/2005/037810A2 |
The invention relates to a compound of formula (I), wherein n ranges from 1 to 6, A is aryl such as phenyl or naphtyle, or monocyclic heteroaryl such as thienyl, furyl or pyrrolyl; aryl or heteroaryl being substituted, if necessary; B is...
|
|
WO/2005/027157A2 |
A salt fusible at ordinary temperature which comprises: a cation ingredient obtained by introducing a cationic group into a volatile organic solvent; and an anion ingredient selected from the group consisting of an inorganic ion, sulfoni...
|
|
WO/2005/014515A2 |
The present invention relates to clear photopolymerisable systems for the preparation of high thickness coatings, to a procedure for their application and to the solid surfaces coated with them.
|
|
WO/2005/014525A2 |
The invention is directed to a bi-aryl compound having a unique immunomodulating activity, a process for a preparation thereof, a pharmaceutical composition containing the same, and a method of preventing or treating disorders or disease...
|
